Nwadibia Ukamaka Nwakife, Potu Kalyan Chakravarthy, Larson Eric A, Ahmed Galal
Department of Internal Medicine, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD.
S D Med. 2017 Jan;70(1):22-24.
In this report, we discuss an unusual case of pulmonary lymphomatoid granulomatosis (LYG), a rare form of angiocentric and angiodestructive lymphoproliferative disorder. This disease is thought to be caused by Epstein-Barr virus-induced lymphoproliferation. A 39-year-old male with no signi ficant past medical history presented with flu-like symptoms. Upon further evaluation, laboratory studies noted pancytopenia, and a chest X-ray showed bilateral nodular densities. A computerized tomography (CT) scan demonstrated bilateral pulmonary nodules and splenomegaly. A biopsy of the pulmonary nodules revealed polymorphous, CD3-positive, lymphohistiocytic, inflammatory in filtrate within the walls of the arterioles and venules with associated necrosis. This histopathology is consistent with LYG. The patient was started on a regimen of rituximab, and he signi ficantly improved within a few weeks after the initiation of therapy, including resolution of the pancytopenia. A repeat CT scan showed the decreased size of the lung nodules. This case was histopathologically consistent with LYG but negative for Epstein-Barr virus ribonucleic acid. This demonstrates the potential for diagnostic difficulty in a case presentation of multiple pulmonary nodules. Extensive work-up for neoplastic, infectious, inflammatory, and autoimmune etiologies needs to be done in such cases. A prompt diagnosis of LYG is necessary for optimal management and improved patient outcomes.